Results 41 to 50 of about 51,092 (200)
Review on t(3;16)(q27;p13), with data on clinics, and the genes ...
Huret, JL
core +1 more source
Review on t(10;11)(p13;q21), with data on clinics, and the genes ...
Huret, JL
core +1 more source
PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13) [PDF]
Recurrent chromosomal abnormalities present in malignant cells often define subentities with unique biological and clinical features. The molecular identification of genes involved in genetic alterations has led to the characterization of fusion genes with neoplastic properties.
S, Strehl +4 more
openaire +2 more sources
Current status of biosimilars in the treatment of inflammatory bowel diseases [PDF]
Introduction of biological therapies have led to dramatic changes in the management of debilitating immune-mediated inflammatory bowel diseases (IBD) including ulcerative colitis and Crohn's disease. However, the long term use of these agents may be very
Dong Il Park
doaj +1 more source
Review on t(2;14)(p13;q32), with data on clinics, and the genes ...
Huret, JL, JL Huret
core +1 more source
Ferulic acid (FA) and p-hydroxybenzoic acid (PHBA) are main phenolic compounds accumulated in rhizosphere of continuously cropped cucumber, causing stress in plants. Microbial degradation of a mixture of FA and PHBA is not well understood in soil.
Fenghui Wu +10 more
doaj +1 more source
Objectives: Infliximab (IFX) is widely used in patients with refractory Takayasu arteritis (TAK). Recently, the IFX-biosimilar CT-P13 has been introduced for the treatment of inflammatory diseases.
Corrado Campochiaro +16 more
doaj +1 more source
Review on t(7;12)(q36;p13), with data on clinics, and the genes ...
Huret, JL, JL Huret
core +1 more source
The P13 potential is the rodent equivalent of the P50 potential, which is an evoked response recorded at the vertex (Vx) 50 msec following an auditory stimulus in humans.
Christen eSimon +4 more
doaj +1 more source
Review on t(8;16)(p11;p13), with data on clinics, and the genes ...
Pérot, C, Huret, JL
core +1 more source

